Antibodies
1 May 2013
Intas launches Mabtas29 April 2013
Peregrine Announces Completion of Patient Enrollment in Breast Cancer Clinical Trial for Bavituximab28 April 2013
MorphoSys Initiates Phase 2 Study of Anti-CD19 Antibody MOR208 in B-cell Acute Lymphoblastic Leukemia26 April 2013
Celltrion initiates phase 1 clinical trial of therapeutic antibody against universal influenza.18 April 2013
TRACON Pharmaceuticals Announces Publication of Mechanism of Action of TRC105, a Novel Anti-Angiogenic Antibody17 April 2013
Compugen Discloses Focused Target Discovery Program for Antibody-Drug Conjugate Cancer Therapy15 April 2013
Springtime for antibody-drug conjugatesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports